Quelles sont les heures d'ouverture ?

Lundi 09:00 - 17:00 Mardi 09:00 - 17:00 Mercredi 09:00 - 17:00 Jeudi 09:00 - 17:00 Vendredi 09:00 - 17:00

Eu2P : European programme in Pharmacovigilance and Pharmacoepidemiology

Accueil
France
Bordeaux
Eu2P : European programme in Pharmacovigilance and Pharmacoepidemiology

Itinéraire Site Web Contacter l'université

Eu2P offers diplomas awarded by a unique consortium of 7 universities & supported by 15 pharmaceutic

Eu2P is a European online education and training programme in pharmacovigilance and pharmacoepidemiology that delivers Master and PhD diplomas, and on-the-job training continuing education certificates. Eu2P is a unique partnership of seven Universities, fifteen pharmaceutical companies, the French and the European medicines agencies. Eu2P is funded by the EU and the EFPIA through the Innovative Medicines Initiative (IMI).

05/10/2026

And we’re off for a new year. Welcome to all the Eu2P students!
Last Friday’s Freshers' Week provided an opportunity to connect with the students and present the programme, its regulations, the online learning platform, and the various subjects taught.
Wishing everyone a great start to their studies!

28/09/2026

Health Authority Expectations for Benefit-Risk Balance Documentation of Generic Medicines in selected MENA Countries
Eu2P Master year 2 oral defence by Ewelina Horoszko-Jagielska

23/09/2026

Post-marketing safety profile of Dolutegravir in people living with HIV in Africa: a narrative review

Master year 1 oral defence by Kgalalelo Mighty Kemelo

23/09/2026

Potential Drug-Drug Interaction at hospital discharge: clinical impacts and potential alternatives. A pilot study in cardiology settings
Master year 1 oral defence by Abrar Gamal Alawad

21/09/2026

Signal detection in company-scale pharmacovigilance databases: a size-scaling analysis of PRR and IC against VigiBase and a clinically adjudicated reference
Master year 2 oral defence by Larysa Kalashnyk

20/07/2026

Beyond the risk management plan: a multi-level analysis of opioid risk minimisation in the European union, with France as a case study
Master year 2 oral defence for Mopelola Adegun

20/07/2026

Congratulations to Esraa Ahmed on the successful discussion of her Master's thesis as part of the Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology! 🎓

Her research, "Assessment of Knowledge, Attitudes, and Perceptions of Healthcare Professionals Toward Adverse Drug Reaction Reporting in the Middle East: A Cross-Sectional Study''.

Her master thesis was directed by Ahmed Hegazy, ISoP Egypt Board Member and Director of PVigilant Health, with academic supervision from Antònia Agustí, Dr. Joan Dsouza, and Immaculada Danés.

Wishing Esraa every success in her future contributions to pharmacovigilance, pharmacoepidemiology, and patient safety. 👏

Eu2P Office

20/07/2026

Patterns in PRAC Regulatory Actions Across Therapeutic Categories: A Descriptive Study of Signal Outcomes (2016-2024)
Master year 2 oral defence for Sara Serdarević

17/07/2026

Assessment of Knowledge, Attitudes, and Perceptions of Healthcare Professionals Toward Adverse Drug Reaction Reporting in the Middle East: A Cross-Sectional Study
Master year 2 oral defence Esraa Ahmed

16/07/2026

Antibiotic Use in the Special Care Baby Unit of a Tertiary Hospital in South-South Nigeria
Master year 2 oral defence for Emmanuel Akalonu

Adresse

Eu2P Central Office, Université De Bordeaux/146 Rue Léo Saignat, Case 36
Bordeaux
33076

Heures d'ouverture

Lundi	09:00 - 17:00
Mardi	09:00 - 17:00
Mercredi	09:00 - 17:00
Jeudi	09:00 - 17:00
Vendredi	09:00 - 17:00

Site Web

https://www.eu2p.org/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Eu2P : European programme in Pharmacovigilance and Pharmacoepidemiology publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.